Cannabis Market in New Hampshire

New Hampshire legalized medical cannabis in 2013 through HB 573, establishing the Therapeutic Cannabis Program administered by the Department of Health and Human Services. The program is notable for its extremely limited license structure — only 4 Alternative Treatment Centers (ATCs) are permitted to operate statewide, each functioning as vertically integrated entities that cultivate, process, and dispense cannabis products.

The state has come close to recreational legalization multiple times. The New Hampshire legislature has passed recreational cannabis bills on several occasions, only to have them vetoed by successive governors. The state decriminalized possession of small amounts of cannabis (up to 3/4 ounce) in 2017, reducing penalties from criminal to civil violations. Despite being the only New England state without recreational legalization, public support for adult-use cannabis is strong.

The medical cannabis market generates an estimated $75 million in annual sales, though its growth is constrained by the limited number of ATCs and their locations. New Hampshire's unique position as a state with no sales tax means that if recreational legalization is eventually enacted, the absence of a general sales tax framework could complicate the design of cannabis-specific excise taxes. The state's proximity to recreational markets in Maine, Massachusetts, and Vermont creates competitive pressure and drives some consumers across state lines. No major MSOs currently operate in New Hampshire due to the ATC model that favors local operators.

The New Hampshire cannabis market is regulated by the New Hampshire Department of Health and Human Services — Therapeutic Cannabis Program, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in New Hampshire is: No specific cannabis excise tax; standard 0% sales tax (NH has no sales tax). Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in New Hampshire must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the New Hampshire cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $75M, and limited MSO presence all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with New Hampshire operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.